ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, a long-term treatment with TKIs frequently fails to eradicate CML cells; as a consequence, the discontinuation of TKIs can cause CML recurrence even if BCR-ABL gene expression cannot be detected for a considerable period with the most sensitive molecular biological methods [61].